פמוזול

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

LETROZOLE 2.5 MG

Saadav alates:

PERRIGO ISRAEL AGENCIES LTD

ATC kood:

L02BG04

Ravimvorm:

FILM COATED TABLETS

Manustamisviis:

PER OS

Valmistatud:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Terapeutiline rühm:

LETROZOLE

Näidustused:

• Femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • Femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .

Loa andmise kuupäev:

2010-11-01